Recent News

• 09.04.2025 - Cidara Therapeutics to Participate in September Investor Conferences
• 09.04.2025 - Cidara Therapeutics to Participate in September Investor Conferences
• 09.03.2025 - Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting
• 09.03.2025 - Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting
• 08.07.2025 - Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
• 08.07.2025 - Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
• 07.24.2025 - Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025
• 07.24.2025 - Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025

Recent Filings

• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2025 - 8-K Current report
• 08.07.2025 - S-8 Securities to be offered to employees in employee benefit plans